Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Allison A. Feduccia, Lisa Jerome, Michael C Mithoefer, Julie Holland
Psychopharmacology (Berl) November 1, 2024 DOI: 10.1007/s00213-024-06671-0 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractTaking certain reuptake-inhibitor medications (such as SSRIs) before MDMA-assisted psychotherapy can affect how well the treatment works. Discontinuing these medications appears to alter patients' therapeutic outcomes. The original article that reported this finding has been retracted.
Study at a glance
| Characteristics | Retraction note Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | MDMA Psychotherapy MDMA-Assisted Therapy Ecstasy therapy Psychotherapeutic MDMA |
| Citations | 6 |
| Key finding | Discontinuation of reuptake inhibitor medications affects treatment response of MDMA-assisted psychotherapy. |
Abstract
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.